Literature DB >> 2455580

Pressor responses induced by Bay K 8644 involve both release of adrenal catecholamines and calcium channel activation.

S Moreland1, M P Ushay, S D Kimball, J R Powell, R S Moreland.   

Abstract

1. The dihydropyridine calcium channel activator, Bay K 8644, is believed to increase mean arterial blood pressure in several animal models, as a result of direct activation of vascular smooth muscle cells by increasing calcium influx through the voltage-dependent calcium channels. The purpose of the current study was to elucidate further the mechanism of action of Bay K 8644, by examining the possibility that the pressor response to Bay K 8644 may also be the result of indirect activation of the vascular smooth muscle cells by release of adrenal catecholamines. 2. Intravenous administration of Bay K 8644 increased mean arterial pressure in a dose-dependent manner in conscious, normotensive rats. This pressor response was blocked by calcium channel blockers (nifedipine, verapamil, and diltiazem) at doses lower than were necessary to decrease resting mean arterial pressure. 3. alpha-Adrenoceptor antagonists (phentolamine, yohimbine, and prazosin) completely blocked the Bay K 8644-induced pressor responses and converted them to depressor responses. Adrenalectomy did not alter the inhibitory effect of phentolamine on the pressor response to Bay K 8644. However, adrenalectomy or adrenal demedullectomy prevented the phentolamine-induced reversal of the Bay K 8644 pressor response to a depressor response. In addition, adrenalectomy did not affect the ability of phentolamine to reverse the pressor response to exogenous adrenaline administration to a depressor response. 4. These data suggest that the pressor response to Bay K 8644 may involve both direct activation of vascular smooth muscle cells and indirect activation of the muscle cells by release of adrenal catecholamines.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455580      PMCID: PMC1853869          DOI: 10.1111/j.1476-5381.1988.tb11490.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Routine direct measurement of arterial pressure in unanesthetized rats.

Authors:  J R WEEKS; J A JONES
Journal:  Proc Soc Exp Biol Med       Date:  1960 Aug-Sep

2.  Positive inotropic actions of the calcium channel stimulator, Bay k 8644, in awake, unsedated dogs.

Authors:  K C Preuss; H L Brooks; G J Gross; D C Warltier
Journal:  Basic Res Cardiol       Date:  1985 May-Jun       Impact factor: 17.165

Review 3.  Mechanisms of action of transmitters and other substances on smooth muscle.

Authors:  T B Bolton
Journal:  Physiol Rev       Date:  1979-07       Impact factor: 37.312

4.  Electromechanical and pharmacomechanical coupling in vascular smooth muscle.

Authors:  A V Somlyo; A P Somlyo
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

5.  Calcium channel activation: a different type of drug action.

Authors:  S B Freedman; R J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

6.  New Ca2+ agonist (Bay K 8644) enhances and induces cardiac slow action potentials.

Authors:  G M Wahler; N Sperelakis
Journal:  Am J Physiol       Date:  1984-08

7.  Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists.

Authors:  P Hess; J B Lansman; R W Tsien
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

8.  Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels.

Authors:  M Schramm; G Thomas; R Towart; G Franckowiak
Journal:  Nature       Date:  1983 Jun 9-15       Impact factor: 49.962

9.  The agonist effect of dihydropyridines on Ca channels.

Authors:  A M Brown; D L Kunze; A Yatani
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

10.  Effects of the novel dihydropyridine BAY-K-8644 on adrenomedullary catecholamine release evoked by calcium reintroduction.

Authors:  C Montiel; A R Artalejo; A G García
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.